Intelligence Platform
Patents
Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9388408
Oligonucleotide-based inhibitors comprising locked nucleic acid motif
granted patentUS 9382256
Formulation of Syk inhibitors
granted patentUS 9382213
Heterocyclic and cyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase
granted patentUS 9375402
Oral formulations of kinase inhibitors
granted patentUS 9375438
Inhibitors of NCCa-ATP channels for therapy
granted patentUS 9376448
DNA-PK inhibitors
granted patentUS 9371337
Ξ²-lactamase inhibitors
granted patentUS 9370505
Pharmaceutical compositions comprising an aromatse inhibitors
granted patentUS 9370519
Macrocyclic FLT3 kinase inhibitors
granted patentUS 9365549
Hepatitis C virus inhibitors
granted patentUS 9365557
Substituted pyrazin-2-amines as inhibitors of ATR kinase
granted patentUS 9365602
Sodium glucose co-transporter inhibitors and methods of their use
granted patentUS 9365612
Caspase inhibitors
granted patentUS 9359309
Synthesis of syrbactin proteasome inhibitors
granted patentUS 9359380
DNA-PK inhibitors
granted patentUS 9359418
Inhibitors of the T cell-specific alternative p38 activation pathway and methods of use
granted patentUS 9353124
Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl
granted patentUS 9353075
Disubstituted beta-lactones as inhibitors of N-acylethanolamine acid amidase (NAAA)
granted patentUS 9353094
Substituted quinoxalines as kinase inhibitors
granted patentUS 9353107
3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitors
granted patentUS 9353126
Substituted triazoles useful as Axl inhibitors
granted patentUS 9345708
Inhibitors of influenza viruses replication
granted patentUS 9345713
6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
granted patentUS 9340546
Compounds useful as inhibitors of ATR kinase
granted